PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942726CE025Ind-enabling studies of pm-208: a NOVEL — Perfusion Medical LLC

Perfusion Medical LLC holds $6.8M across 5 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: SBA. Recompete timing centers on the Aug 9, 2027 PoP end — agencies typically plan 12–18 months ahead.

Defense Health Agency

Awarding office

Perfusion Medical LLC

Recipient

Aug 9, 2027

PoP end

$1.5M

Obligated

$1.5M

Potential

541715

NAICS

AN12

PSC

SBA

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Perfusion Medical LLC — $90

Contract facts

SBA

Contract numberHT942726CE025

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentPerfusion Medical LLC

CAGE8MYE9

UEIXEDJGXP1K889

NAICS541715

PSCAN12

Place of performanceHERNDON VA

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition After Exclusion Of Sources

Related solicitationHQ003420RBDST

PoP startApr 10, 2026

PoP end (current)Aug 9, 2027

Obligated$1.5M

Current value$1.5M

Potential value$1.5M

IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC is a federal SBA award for Defense Health Agency held by Perfusion Medical LLC. Estimated value $1.5M ($1.5M obligated). Current period of performance ends Aug 9, 2027. Last award drew 1 bidder. Place of performance: HERNDON VA. Related solicitation HQ003420RBDST.

IND-ENABLING STUDIES OF PM-208: A NOVEL PRE-HOSPITAL ANTI-SHOCK THERAPEUTIC

Recompete timing

Public

● Expiring in 336 days

Current PoP ends Aug 9, 2027 (336 days remaining). Agencies typically plan 12–18 months ahead — at 11.0 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Perfusion Medical LLC — $6.8M obligated across 5 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)

Department of Defense (DOD)$6.8M · 100% of firm total

Open full company profile →

Related awards

Same incumbent

FA864924P0531

HUMAN CLINICAL TRIAL FOR SAFETY OF PM-208 ANTI-SHOCK DRUG

$1.8M

Jan 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT942726CE025?

HT942726CE025 (Ind-enabling studies of pm-208: a NOVEL) is a Defense Health Agency award with a potential value of $1.5M, currently held by Perfusion Medical LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded HT942726CE025?

Defense Health Agency awarded HT942726CE025 to Perfusion Medical LLC (potential $1.5M).

Who is the incumbent on HT942726CE025?

Perfusion Medical LLC is the incumbent with $6.8M across 5 related awards in SCOUT’s public footprint. The current period of performance ends Aug 9, 2027.

When does Perfusion Medical LLC’s HT942726CE025 come up for recompete?

SCOUT tracks a period-of-performance end of Aug 9, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on HT942726CE025 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jul 2, 2026 · refreshed monthlyLatest procurement action Apr 3, 2026